Endothelium-Derived Hyperpolarizing Factor in the Brain: Influence of Sex, Vessel Size and Disease State
Author(s) -
Catherine M. Davis,
Dominic A. Siler,
Nabil J. Alkayed
Publication year - 2011
Publication title -
women s health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.363
H-Index - 39
eISSN - 1745-5065
pISSN - 1745-5057
DOI - 10.2217/whe.11.26
Subject(s) - endothelium derived hyperpolarizing factor , endothelium , medicine , prostacyclin , endothelial dysfunction , vasodilation , microvessel , nitric oxide , stroke (engine) , disease , neuroscience , cardiology , endocrinology , angiogenesis , biology , mechanical engineering , charybdotoxin , engineering
The endothelial layer of cells lining the intimal surface of blood vessels is essential for vascular function. The endothelium releases multiple vasodilator and protective factors, including nitric oxide, prostacyclin and endothelium-derived hyperpolarizing factor; an imbalance in these factors predisposes individuals to vascular diseases such as stroke. These factors are differentially regulated by vessel size, sex hormones and disease state, therefore playing differential roles in different tissues following vascular injury. In particular, the endothelium-derived hyperpolarizing factor candidate termed epoxyeicosatrienoic acid, plays a prominent role in microvessel function, especially after ischemia, thereby making this signaling pathway an attractive target for therapy in vascular disease, including stroke.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom